Primary aldosteronism (PA), a common, albeit markedly underdiagnosed cause of curable
arterial hypertension, is characterized by plasma levels of aldosterone that are inappropriate …

Primary aldosteronism (PA) was first reported by Jerome W. Conn in 1954 when it was
considered a rare disorder, only suspected in cases of hypertension and spontaneous …

Primary aldosteronism (PA) is the most frequent endocrine form of secondary hypertension.
The recognition of this disease has dramatically increased with the widespread use of a …

Primary aldosteronism (PA) is a common cause of arterial hypertension: in the PA
Prevalence in Hypertensives (PAPY) Study, the prevalence of PA was 11.2% in consecutive …

After discussing in Part I (Rossi et al, J Nephrol. 2008; 21: 447-454) the screening strategy to
identify the hypertensive patients with primary aldosteronism (PA), we report here an update …

Despite carrying an excess risk of cardiovascular events, primary aldosteronism (PA) is a
commonly overlooked secondary form of arterial hypertension. An increased awareness of …

Background Primary aldosteronism is much more common than previously held; it implies
an excessive organ damage to the heart, vessels and kidney, which translates into an …

Primary aldosteronism (PAL) is characterised by aldosterone production which is excessive
to the body's requirements and relatively autonomous of its normal chronic regulator …

Primary aldosteronism (PA), the most common form of secondary hypertension, can be
either surgically cured or treated with targeted pharmacotherapy. PA is frequently …

These findings would have been no surprise to Jerome Conn. As early as 1964, within a few
years of his first description of primary aldosteronism, Conn [12] aroused heated debate by …